HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

SMS Pharmaceuticals Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 59 filings·Updated 21 Aug 2026
Showing 10 of 59 filings.
21 Aug 20262 filings
Company UpdateNewspaper Publication

Copy of newspaper publication regarding the 38th Annual General Meeting to be held through VC/ other Audio Visual Means

Filed 16:42View Source
Company UpdateCopy of Newspaper Publication

SMS Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

Filed 16:40View Source
29 Jul 20261 filing
Company UpdateBoard Meeting Rescheduled

Board meeting rescheduled to July 31, 2026; trading window dates updated

Board meeting reschedule

  • Board meeting rescheduled from 1 August 2026 to 31 July 2026.
  • Original date: 01 Aug 2026; new date: 31 Jul 2026.
  • Agenda: approve unaudited Q1 standalone & consolidated results for June 30, 2026.
  • Reason: unavoidable administrative exigencies.
  • Trading window closes July 1, 2026 to August 2, 2026; reopens August 3, 2026.
Filed 12:25View Source
25 Jul 20261 filing
Board Meeting

SMS Pharmaceuticals Board to consider unaudited Q1 FY2026 results; trading window closes July 1–Aug 3, 2026.

Meeting Details

  • Date: 1 August 2026; Venue: Registered Office, 8th Floor Trendset Jayabheri Connect, Kondapur, Serilingampally, Ranga Reddy Dist., Hyderabad.

Key Agenda Items

  • Consider and approve unaudited standalone and consolidated financial results for Q1 ended 30 June 2026.

Other Notes

  • Trading window closed from July 1 to August 3, 2026 inclusive; reopen August 4, 2026.
Filed 15:39View Source
22 Jul 20262 filings
Company UpdateNewspaper Publication

Copy of Newspaper Publication for information regarding transfer of shares to IEPF.

Filed 12:43View Source
Company UpdateCopy of Newspaper Publication

SMS Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

Filed 12:32View Source
20 Jul 20262 filings
Company UpdateGeneral

SMS Pharmaceuticals reports arrest in share-impersonation case; investigation ongoing

Update on share-impersonation case

  • Police have arrested one person allegedly involved in the share-impersonation case.
  • The suspect appeared before the Hyderabad XII CJM on 19 July 2026 for remand.
  • Matter remains under further police investigation with no disclosed material financial impact.
  • Company will continue to pursue appropriate legal and regulatory measures.
Filed 17:10View Source
Company UpdateGeneral

SMS Pharmaceuticals Limited reports arrest in impersonation of shares case; investigation ongoing

Impersonation case update

  • Police investigation into shares impersonation ongoing; one suspect arrested.
  • Suspect produced before XII Additional Chief Judicial Magistrate, Hyderabad on 19 July 2026 for remand.
  • Matter under further investigation; company to pursue legal and regulatory actions.
  • No financial impact or operational changes disclosed at this time.
Filed 17:05View Source
7 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) SEBI DP Regulations: Dematerialisation actions completed

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

  • Dematerialisation actions completed within 15 days of certificate receipt by the registrar.
  • Dematerialised securities are listed on stock exchanges.
  • Physical certificates for dematerialisation mutilated and cancelled.
  • Depository name substituted as registered owner in records.
Filed 12:42View Source
1 Jul 20261 filing
Company UpdateGeneral

SMS Pharmaceuticals clarifies price/volume movement is market-driven; no pending disclosures

Clarification on price/volume movement

  • Company states full compliance with Regulation 30 LODR and timely disclosure of price-sensitive information.
  • No pending information or events expected to affect volume or price in the scrip.
  • Price movement is attributed to market conditions and is market-driven.
  • Dated 01 July 2026; no material information disclosed.
  • Requests exchange records to note the clarification.
Filed 15:26View Source
Showing 10 of 59 filings